Pascal Chanez

46.2k total citations · 10 hit papers
447 papers, 25.6k citations indexed

About

Pascal Chanez is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Pascal Chanez has authored 447 papers receiving a total of 25.6k indexed citations (citations by other indexed papers that have themselves been cited), including 315 papers in Physiology, 237 papers in Pulmonary and Respiratory Medicine and 72 papers in Immunology. Recurrent topics in Pascal Chanez's work include Asthma and respiratory diseases (303 papers), Respiratory and Cough-Related Research (125 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (92 papers). Pascal Chanez is often cited by papers focused on Asthma and respiratory diseases (303 papers), Respiratory and Cough-Related Research (125 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (92 papers). Pascal Chanez collaborates with scholars based in France, United States and United Kingdom. Pascal Chanez's co-authors include Jean Bousquet, Philippe Godard, Isabelle Vachier, Ian Pavord, Héctor Ortega, Oliver N. Keene, Eugene R. Bleecker, Peter Howarth, I. Enander and Stephanie Korn and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Pascal Chanez

424 papers receiving 24.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Eosinophilic Inflammation in Asthma

1990 2.1k citations Jean Bousquet, Pascal Chanez et al. profile →
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

2014 1.6k citations Ian Pavord, Guy Brusselle et al. profile →
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

2012 1.6k citations Ian Pavord, Stephanie Korn et al. profile →
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

2016 976 citations Pascal Chanez, Alberto Papi et al. profile →
Induction of nitric oxide synthase in asthma

1993 700 citations Pascal Chanez, Jean Bousquet et al. profile →
Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells

2015 434 citations Martijn J. Schuijs, Monique Willart et al. Science profile →
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

2014 406 citations Pascal Chanez et al. profile →
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

2017 384 citations Ian Pavord, Pascal Chanez et al. profile →
Eosinophils in Health and Disease: A State-of-the-Art Review

2021 164 citations Michael E. Wechsler, Ariel Munitz et al. Mayo Clinic Proceedings profile →
Airway remodelling in asthma and the epithelium: on the edge of a new era

2024 44 citations Bart N. Lambrecht, Pascal Chanez et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by Pascal Chanez

Since Specialization

Citations

This map shows the geographic impact of Pascal Chanez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Chanez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Chanez more than expected).

Fields of papers citing papers by Pascal Chanez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Chanez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Chanez. The network helps show where Pascal Chanez may publish in the future.

Co-authorship network of co-authors of Pascal Chanez

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Chanez. A scholar is included among the top collaborators of Pascal Chanez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Chanez. Pascal Chanez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial 2025 ·The Lancet Respiratory Medicine ·David J. Jackson, Njira Lugogo, (unknown), Liam G. Heaney, Stephanie Korn, Guy Brusselle, Pascal Chanez, (unknown), Jean‐Pierre Llanos, (unknown), Kinga Sałapa, Bill Cook, Amit Parulekar, (unknown), Robert Fogel, Neil A. Martin, Shamir Chandarana	0
2	Tezepelumab Reduces and Eliminates OCS Use in OCS-Dependent Patients With Severe Asthma: Primary Results from the Phase 3b WAYFINDER Study 2025 ·American Journal of Respiratory and Critical Care Medicine ·David J. Jackson, Njira Lugogo, Mark Gurnell, Liam G. Heaney, (unknown), (unknown), Pascal Chanez, (unknown), Jean‐Pierre Llanos, (unknown), Kinga Sałapa, (unknown), Κonstantinos Κostikas, Robert Fogel, (unknown), Shamir Chandarana	1
3	EFFICACY OF BENRALIZUMAB AND MEPOLIZUMAB ON ASTHMA OUTCOMES IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 2024 ·Annals of Allergy Asthma & Immunology ·(unknown), Arnaud Bourdin, Pascal Chanez, David J. Jackson, Shahid Siddiqui, U. Specks, (unknown), (unknown)	1
4	Occupational exposure to aerosols in two French airports: multi-year lung function changes 2024 ·Annals of Work Exposures and Health ·(unknown), Adeline Tarantini, Carey Suehs, Erika Nogué, Caroline Marie, (unknown), (unknown), Jean‐Luc Ravanat, (unknown), (unknown), (unknown), (unknown), (unknown), Pascal Chanez, Isabelle Vachier, Nicolas Molinari	1
5	Platelets Purification Is a Crucial Step for Transcriptomic Analysis 2022 ·International Journal of Molecular Sciences ·(unknown), Saïd Assou, Véronique Pantesco, Catherine Duez, Marie‐Christine Alessi, Pascal Chanez, Delphine Gras	9
6	Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study 2021 ·Therapeutic Advances in Respiratory Disease ·(unknown), Carey Suehs, Khuder Alagha, Arnaud Bourdin, (unknown), Jérémy Charriot, Gilles Devouassoux, Stéphanie Fry, Laurent Guilleminault, M. Gouitaa, Camille Taillé, Pascal Chanez, Laurie Pahus	2
7	Eosinophils in Health and Disease: A State-of-the-Art Review breakdown → 2021 ·Mayo Clinic Proceedings ·Michael E. Wechsler, Ariel Munitz, Steven J. Ackerman, Matthew G. Drake, David J. Jackson, Andrew J. Wardlaw, Stephanie K. Dougan, Sergejs Berdnikovs, Florence Schleich, Andrea Matucci, Pascal Chanez, Charlene M. Prazma, Peter Howarth, Peter F. Weller, Peter A. Merkel	164
8	Active mucus–cilia hydrodynamic coupling drives self-organization of human bronchial epithelium 2020 ·Nature Physics ·Étienne Loiseau, Simon Gsell, (unknown), (unknown), Delphine Gras, Pascal Chanez, Umberto D’Ortona, Laurent Kodjabachian, Julien Favier, Annie Viallat	40
9	Protein crystallization promotes type 2 immunity and is reversible by antibody treatment 2019 ·Science ·Emma K. Persson, Kenneth Verstraete, Ines Heyndrickx, Elien Gevaert, Helena Aegerter, (unknown), Kim Deswarte, Koen H. G. Verschueren, Ann Dansercoer, Delphine Gras, Pascal Chanez, Claus Bachert, Amanda Gonçalves, Hanne Van Gorp, Hans de Haard, Christophe Blanchetot, Michael Saunders, Hamida Hammad, Savvas N. Savvides, Bart N. Lambrecht	207
10	Evaluation of Eosinophilic Asthma Patients Without Blood Eosinophil (EOS) Response to Intravenous (IV) Reslizumab in a Post-Hoc Analysis of 52-Week Placebo-Controlled Phase 3 Studies 2019 ·Journal of Allergy and Clinical Immunology ·Pascal Chanez, Lisa Hickey, Margaret Garin, Mario Castro	2
11	Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells breakdown → 2015 ·Science ·Martijn J. Schuijs, Monique Willart, Karl Vergote, Delphine Gras, Kim Deswarte, Markus Ege, (unknown), Rudi Beyaert, Geert Loo, Franz Bracher, Erika von Mutius, Pascal Chanez, Bart N. Lambrecht, Hamida Hammad	434
12	Frequent exacerbators - a distinct phenotype of severe asthma 2014 ·Homo Politicus (Academy of Humanities and Economics in Lodz) ·Alberto Papi, Pascal Chanez, Maciej Kupczyk, (unknown), (unknown), (unknown), Ewa Niżankowska‐Mogilnicka, Mark Gjomarkaj, Mina Gaga, Guy Brusselle, Barbro Dahlén, (unknown)	116
13	Solitary cystic mediastinal lymphangioma 2013 ·European Respiratory Review ·(unknown), Pascale Tomasini, Delphine Trousse, Fabien Maldonado, Pascal Chanez, P. Astoul	13
14	Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial 2010 ·European Respiratory Journal ·Stephen T. Holgate, Michael Noonan, Pascal Chanez, William W. Busse, Lieven Dupont, Ian Pavord, A. Hakulinen, L Paolozzi, Joseph Wajdula, Chuanbo Zang, Harold S. Nelson, Donald G. Raible	134
15	Clinical COPD phenotypes: a novel approach using principal component and cluster analyses 2010 ·European Respiratory Journal ·Pierre‐Régis Burgel, (unknown), D. Caillaud, Isabelle Tillie‐Leblond, Pascal Chanez, R. Escamilla, I. Court-Fortuné, T. Pérez, Philippe Carré, Nicolás Roche	240
16	Persistent Activation of Nuclear Factor–κB Signaling Pathway in Severe Uncontrolled Asthma 2003 ·American Journal of Respiratory and Critical Care Medicine ·Rosalia Gagliardo, Pascal Chanez, Marc Mathieu, Andreina Bruno, (unknown), C. Gougat, Isabelle Vachier, Jean Bousquet, G Bonsignore, Antonio M. Vignola	134
17	The response of two different dosages of beclometasone diporpionate suspension for nebulization versus a standard dose of beclometasone dipropionate via a metered-dose inhaler on bronchoprovocation testing in adults with asthma 2003 ·Respiratory Medicine ·Jean Bousquet, (unknown), Pascal Chanez, (unknown), (unknown)	4
18	Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? 2003 ·European Respiratory Journal ·Éric Marchand, B. Étienne-Mastroïanni, Pascal Chanez, D. Lauque, (unknown), (unknown), (unknown)	78
19	2015 NYAR (Savannah) Program 1997 ·PubMed ·Jean Bousquet, Pascal Chanez, Ashley Campbell, (unknown)	1
20	Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma 1992 ·Journal of Allergy and Clinical Immunology ·(unknown), Pascal Chanez, Christine De Vos, (unknown), A.M. Clauzel, François-Bernard Michel, Philippe Godard	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact